Real-time enrollment status for this recurrent multiple myeloma clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 11:50 PM UTC
| NCT Number | NCT06622005 |
| Recruiting Status | Recruiting |
| Condition | Recurrent Multiple Myeloma |
| Phase | PHASE1 |
| Target Enrollment | 15 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Roswell Park Cancer Institute |
| Last Updated on CT.gov | August 13, 2026 (2 weeks ago) |
As of August 28, 2026: Clinical trial NCT06622005 is currently recruiting participants. This phase1 study for recurrent multiple myeloma is actively seeking new participants at 1 location across the United States. The study is sponsored by Roswell Park Cancer Institute. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06622005 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06622005 was last updated 2 weeks ago (August 13, 2026). HelloStudys verifies this status automatically.